132 related articles for article (PubMed ID: 36418540)
1. X-linked dystonia parkinsonism: epidemiology, genetics, clinical features, diagnosis, and treatment.
Chin HL; Lin CY; Chou OH
Acta Neurol Belg; 2023 Feb; 123(1):45-55. PubMed ID: 36418540
[TBL] [Abstract][Full Text] [Related]
2. A scoping review on the diagnosis and treatment of X-linked dystonia-parkinsonism.
Alonto AHD; Jamora RDG
Parkinsonism Relat Disord; 2024 Feb; 119():105949. PubMed ID: 38072720
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of X-linked dystonia parkinsonism disease striatal neurons reveals altered RNA metabolism and splicing.
Tshilenge KT; Bons J; Aguirre CG; Geronimo-Olvera C; Shah S; Rose J; Gerencser AA; Mak SK; Ehrlich ME; Bragg DC; Schilling B; Ellerby LM
Neurobiol Dis; 2024 Jan; 190():106367. PubMed ID: 38042508
[TBL] [Abstract][Full Text] [Related]
4. Dissecting the Causal Mechanism of X-Linked Dystonia-Parkinsonism by Integrating Genome and Transcriptome Assembly.
Aneichyk T; Hendriks WT; Yadav R; Shin D; Gao D; Vaine CA; Collins RL; Domingo A; Currall B; Stortchevoi A; Multhaupt-Buell T; Penney EB; Cruz L; Dhakal J; Brand H; Hanscom C; Antolik C; Dy M; Ragavendran A; Underwood J; Cantsilieris S; Munson KM; Eichler EE; Acuña P; Go C; Jamora RDG; Rosales RL; Church DM; Williams SR; Garcia S; Klein C; Müller U; Wilhelmsen KC; Timmers HTM; Sapir Y; Wainger BJ; Henderson D; Ito N; Weisenfeld N; Jaffe D; Sharma N; Breakefield XO; Ozelius LJ; Bragg DC; Talkowski ME
Cell; 2018 Feb; 172(5):897-909.e21. PubMed ID: 29474918
[TBL] [Abstract][Full Text] [Related]
5. Motor assessment of X-linked dystonia parkinsonism via machine-learning-based analysis of wearable sensor data.
Parisi F; Corniani G; Bonato P; Balkwill D; Acuna P; Go C; Sharma N; Stephen CD
Sci Rep; 2024 Jun; 14(1):13229. PubMed ID: 38853162
[TBL] [Abstract][Full Text] [Related]
6. X-Linked Parkinsonism: Phenotypic and Genetic Heterogeneity.
Di Lazzaro G; Magrinelli F; Estevez-Fraga C; Valente EM; Pisani A; Bhatia KP
Mov Disord; 2021 Jul; 36(7):1511-1525. PubMed ID: 33960519
[TBL] [Abstract][Full Text] [Related]
7. Neuroenergetic Changes in Patients with X-Linked Dystonia-Parkinsonism and Female Carriers.
Prasuhn J; Henkel J; Algodon SM; Uter J; Rosales RL; Klein C; Steinhardt J; Diesta CC; Brüggemann N
Mov Disord Clin Pract; 2024 May; 11(5):550-555. PubMed ID: 38404049
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing reduced penetrance and variable expressivity in X-linked dystonia-parkinsonism.
Pozojevic J; von Holt BH; Westenberger A
Med Genet; 2022 Jun; 34(2):97-102. PubMed ID: 38835911
[TBL] [Abstract][Full Text] [Related]
9. X-linked dystonia-parkinsonism: over and above a repeat disorder.
Pozojevic J; Cruz JN; Westenberger A
Med Genet; 2021 Dec; 33(4):319-324. PubMed ID: 38835428
[TBL] [Abstract][Full Text] [Related]
10. Evidence of TAF1 dysfunction in peripheral models of X-linked dystonia-parkinsonism.
Domingo A; Amar D; Grütz K; Lee LV; Rosales R; Brüggemann N; Jamora RD; Cutiongco-Dela Paz E; Rolfs A; Dressler D; Walter U; Krainc D; Lohmann K; Shamir R; Klein C; Westenberger A
Cell Mol Life Sci; 2016 Aug; 73(16):3205-15. PubMed ID: 26879577
[TBL] [Abstract][Full Text] [Related]
11. Mini-heterochromatin domains constrain the cis-regulatory impact of SVA transposons in human brain development and disease.
Horváth V; Garza R; Jönsson ME; Johansson PA; Adami A; Christoforidou G; Karlsson O; Castilla Vallmanya L; Koutounidou S; Gerdes P; Pandiloski N; Douse CH; Jakobsson J
Nat Struct Mol Biol; 2024 Jun; ():. PubMed ID: 38834915
[TBL] [Abstract][Full Text] [Related]
12. Stability of Mosaic Divergent Repeat Interruptions in X-Linked Dystonia-Parkinsonism.
Laß J; Lüth T; Schlüter K; Schaake S; Laabs BH; Much C; Jamora RD; Rosales RL; Saranza G; Diesta CCE; Pearson CE; König IR; Brüggemann N; Klein C; Westenberger A; Trinh J
Mov Disord; 2024 Apr; ():. PubMed ID: 38616406
[TBL] [Abstract][Full Text] [Related]
13. SAK3 confers neuroprotection in the neurodegeneration model of X-linked Dystonia-Parkinsonism.
Aryal S; Chen S; Burbach KF; Yang Y; Capano LS; Kim WK; Bragg DC; Yoo A
Res Sq; 2024 Apr; ():. PubMed ID: 38746402
[TBL] [Abstract][Full Text] [Related]
14. Parkinsonism-dystonia-2: Case-series study from Saudi Arabia.
Almuqbil MA; Tabassum S; Muthaffar OY; Ghamdi F; Al Masseri Z; Alsaman A; Alkhater RA
Ann Clin Transl Neurol; 2024 Apr; 11(4):1063-1066. PubMed ID: 38389300
[TBL] [Abstract][Full Text] [Related]
15. Taf1 knockout is lethal in embryonic male mice and heterozygous females show weight and movement disorders.
Crombie EM; Korecki AJ; Cleverley K; Adair BA; Cunningham TJ; Lee WC; Lengyell TC; Maduro C; Mo V; Slade LM; Zouhair I; Fisher EMC; Simpson EM
Dis Model Mech; 2024 May; ():. PubMed ID: 38804708
[TBL] [Abstract][Full Text] [Related]
16. Dystonia and parkinsonism: Not an easy combo.
Montiel M; Fasano A
Parkinsonism Relat Disord; 2024 Jun; 123():106009. PubMed ID: 38233325
[No Abstract] [Full Text] [Related]
17. Commentary: Juvenile Dystonia-Parkinsonism due to
Barsottini O; Garza-Brambila D; Esparza-Hernández CN; Ramirez-Zenteno J; Martinez-Ramirez D; Fasano A
Mov Disord Clin Pract; 2021 Aug; 8(Suppl 1):S29-S31. PubMed ID: 34514043
[No Abstract] [Full Text] [Related]
18. Reply to: Familial Hypermanganesemia in Iran.
Garg D; Sharma S
Mov Disord Clin Pract; 2023 May; 10(5):854-855. PubMed ID: 37205241
[No Abstract] [Full Text] [Related]
19. Nonmotor Symptoms in Dystonia: Pathophysiological Implications.
Mishra A; Pandey S
Ann Indian Acad Neurol; 2020; 23(4):425-426. PubMed ID: 33223654
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
